PLoS One 2009, 4:e4576.PubMedCrossRef 13. Pircher A, Ploner F, Popper H, Hilbe

W: Rationale of a relaunch of gefitinib in Selleckchem CX-5461 Caucasian non-small cell lung cancer patients. Lung Cancer 69:265–271. 14. Riely GJ, Marks J, Pao W: KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc 2009, 6:201–205.PubMedCrossRef 15. Roberts PJ, Stinchcombe TE, Der CJ, Socinski MA: Personalized Medicine in Non-Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor-Targeted Therapy? J Clin Oncol 2011. 16. Tanaka T, Matsuoka M, Sutani A, Gemma A, Maemondo M, Inoue A, Okinaga S, Nagashima M, Oizumi S, Uematsu K, Nagai Y, Moriyama G, Miyazawa H, LGX818 purchase Ikebuchi K, Morita S, Kobayashi K, Hagiwara K: Frequency of and variables associated with the EGFR mutation and its subtypes. Int J Cancer 126:651–655. 17. Masago K, Fujita S, Mio T, Ichikawa M, Sakuma K, Kim YH, Hatachi Y, Fukuhara A, Kamiyama K, Sonobe M, Miyahara R, Date H, Mishima M: Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients. Int J Clin Oncol 2008, 13:442–446.PubMedCrossRef 18. Nagai Y,

Miyazawa H, Huqun , Tanaka T, Udagawa K, Kato M, Fukuyama S, Yokote A, Kobayashi K, Kanazawa M, Hagiwara K: Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the HSP inhibitor review peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 2005, 65:7276–7282.PubMedCrossRef 19. Tanaka T, Nagai Y, Miyazawa H, Koyama N, Matsuoka S, Sutani A, Huqun , Udagawa K, Murayama Y, Nagata M, Shimizu Y, Ikebuchi K, Kanazawa M, Kobayashi K, Hagiwara K: Reliability of the peptide nucleic acid-locked Cyclin-dependent kinase 3 nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical

practice for non-small cell lung cancers. Cancer Sci 2007, 98:246–252.PubMedCrossRef 20. Kimura H, Kasahara K, Kawaishi M, Kunitoh H, Tamura T, Holloway B, Nishio K: Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Clin Cancer Res 2006, 12:3915–3921.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions SD carried out the molecular analysis, MJR participated in the design of the study and drafted the manuscript, SL carried out immunohistochemestry analysis, FdeF designed the study, carried out the molecular analysis and drafted the manuscript. All authors reviewed the draft manuscript, read and approved the final version for submission.